PetIQ Inc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $17.365
- Today's High:
- $18.245
- Open Price:
- $17.41
- 52W Low:
- $6.66
- 52W High:
- $20.865
- Prev. Close:
- $17.41
- Volume:
- 294805
Company Statistics
- Market Cap.:
- $512.23 million
- Book Value:
- 8.007
- Revenue TTM:
- $998.82 million
- Operating Margin TTM:
- 4.67%
- Gross Profit TTM:
- $209.66 million
- Profit Margin:
- -3.68%
- Return on Assets TTM:
- 3.36%
- Return on Equity TTM:
- -14.76%
Company Profile
PetIQ Inc had its IPO on 2017-07-21 under the ticker symbol PETQ.
The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. PetIQ Inc has a staff strength of 1,076 employees.
Stock update
Shares of PetIQ Inc opened at $17.41 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $17.37 - $18.25, and closed at $18.1.
This is a +3.96% increase from the previous day's closing price.
A total volume of 294,805 shares were traded at the close of the day’s session.
In the last one week, shares of PetIQ Inc have slipped by -5.29%.
PetIQ Inc's Key Ratios
PetIQ Inc has a market cap of $512.23 million, indicating a price to book ratio of 1.5409 and a price to sales ratio of 0.3449.
In the last 12-months PetIQ Inc’s revenue was $998.82 million with a gross profit of $209.66 million and an EBITDA of $81.48 million. The EBITDA ratio measures PetIQ Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, PetIQ Inc’s operating margin was 4.67% while its return on assets stood at 3.36% with a return of equity of -14.76%.
In Q2, PetIQ Inc’s quarterly earnings growth was a positive 102.3% while revenue growth was a positive 24.8%.
PetIQ Inc’s PE and PEG Ratio
- Forward PE
- 7.776
- Trailing PE
- 0
- PEG
- 0.9717
Its diluted EPS in the last 12-months stands at $-1.23 per share while it has a forward price to earnings multiple of 7.776 and a PEG multiple of 0.9717. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into PetIQ Inc’s profitability.
PetIQ Inc stock is trading at a EV to sales ratio of 0.7997 and a EV to EBITDA ratio of 71.3508. Its price to sales ratio in the trailing 12-months stood at 0.3449.
PetIQ Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $883.47 million
- Total Liabilities
- $191.70 million
- Operating Cash Flow
- $-2218000.00
- Capital Expenditure
- $2.22 million
- Dividend Payout Ratio
- 0%
PetIQ Inc ended 2024 with $883.47 million in total assets and $0 in total liabilities. Its intangible assets were valued at $883.47 million while shareholder equity stood at $233.64 million.
PetIQ Inc ended 2024 with $0 in deferred long-term liabilities, $191.70 million in other current liabilities, 29000.00 in common stock, $-143566000.00 in retained earnings and $204.20 million in goodwill. Its cash balance stood at $78.44 million and cash and short-term investments were $78.44 million. The company’s total short-term debt was $14,363,000 while long-term debt stood at $440.58 million.
PetIQ Inc’s total current assets stands at $422.44 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $193.57 million compared to accounts payable of $154.14 million and inventory worth $141.65 million.
In 2024, PetIQ Inc's operating cash flow was $-2218000.00 while its capital expenditure stood at $2.22 million.
Comparatively, PetIQ Inc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $18.1
- 52-Week High
- $20.865
- 52-Week Low
- $6.66
- Analyst Target Price
- $27.5
PetIQ Inc stock is currently trading at $18.1 per share. It touched a 52-week high of $20.865 and a 52-week low of $20.865. Analysts tracking the stock have a 12-month average target price of $27.5.
Its 50-day moving average was $17.54 and 200-day moving average was $13.19 The short ratio stood at 3.83 indicating a short percent outstanding of 0%.
Around 667.5% of the company’s stock are held by insiders while 9367.1% are held by institutions.
Frequently Asked Questions About PetIQ Inc
Similar Industry Stocks (Drug Manufacturers-Specialty & Generic)
Most Active
Top Gainers
Top Losers
About
PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at community clinics and wellness centers hosted at pet retailers, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.